Correction to: AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis (Apoptosis, (2014), 19, 8, (1254-1268), 10.1007/s10495-014-1001-4);AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis

Apoptosis

Volumn 19, Issue 8, 2014, Pages 1254-1268

  Liu, Yu ^a   Yang, Hui ^a   Song, Lina ^a   Li, Nan ^a   Han, Qiu Yue ^a   Tian, Cui ^a,b   Gao, Erhe ^c   Du, Jie ^a   Xia, Yun Long ^d   Li, Hui Hua ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

AGGF1; Angiogenesis signaling pathways; Apoptosis; Inflammation; Ischemia reperfusion; Myocardium

Indexed keywords

ANGIOGENIC PROTEIN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; NEUTRALIZING ANTIBODY; PROTEIN AGGF1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN AGGF1; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN; AGGF1 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; HEART INFARCTION; HEART MUSCLE; HUMAN; IMMUNOLOGY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; SPRAGUE DAWLEY RAT;

MUS;

ANGIOGENIC PROTEINS; ANIMALS; ANTIBODIES, NEUTRALIZING; APOPTOSIS; CELLS, CULTURED; HUMANS; INFLAMMATION; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84904244477     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-021-01695-9     Document Type: Erratum

References (37)

1. Hosoda T, Kajstura J, Leri A, Anversa P (2010) Mechanisms of myocardial regeneration. Circ J 74:13-17
2. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ et al (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61:414-426 (Pubitemid 38210148)
3. El-Menyar AA (2008) Cytokines and myocardial dysfunction: state of the art. J Card Fail 14:61-74
4. Armstrong SC (2004) Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61:427-436
5. Tabibiazar R, Rockson SG (2001) Angiogenesis and the ischaemic heart. Eur Heart J 22:903-918 (Pubitemid 32625213)
6. Syed IS, Sanborn TA, Rosengart TK (2004) Therapeutic angiogenesis: a biologic bypass. Cardiology 101:131-143 (Pubitemid 38339715)
7. Mitsos S, Katsanos K, Koletsis E, Kagadis GC, Anastasiou N, Diamantopoulos A et al (2012) Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials. Angiogenesis 15:1-22
8. Han Y, Yang K, Proweller A, Zhou G, Jain MK, Ramirez-Bergeron DL (2012) Inhibition of ARNT severely compromises endothelial cell viability and function in response to moderate hypoxia. Angiogenesis 15:409-420
9. Timur AA, Driscoll DJ, Wang Q (2005) Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci 62:1434-1447 (Pubitemid 40922947)
10. Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L et al (2004) Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427:640-645 (Pubitemid 38248484)
11. Fan C, Ouyang P, Timur AA, He P, You SA, Hu Y et al (2009) Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function. J Biol Chem 284:23331-23343
12. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ et al (2004) Atrogin-1/muscle atrophy F-box inhibits calcineur-independent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114:1058-1071 (Pubitemid 39578695)
13. Zheng W, Seftor EA, Meininger CJ, Hendrix MJ, Tomanek RJ (2001) Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta. Am J Physiol Heart Circ Physiol 280:H909-H917
14. Zheng W, Christensen LP, Tomanek RJ (2004) Stretch induces upregulation of key tyrosine kinase receptors in microvascular endothelial cells. Am J Physiol Heart Circ Physiol 287:H2739-H2745 (Pubitemid 39557147)
15. Xie P, Guo S, Fan Y, Zhang H, Gu D, Li H (2009) Atrogin-1/ MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation. J Biol Chem 284:5488-5496
16. Zhang Y, Zeng Y, Wang M, Tian C, Ma X, Chen H et al (2011) Cardiac-specific overexpression of E3 ligase Nrdp1 increases ischemia and reperfusion-induced cardiac injury. Basic Res Cardiol 106:371-383
17. Amaral SL, Maier KG, Schippers DN, Roman RJ, Greene AS (2003) CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol 284:H1528-H1535 (Pubitemid 36460763)
18. Besse S, Boucher F, Linguet G, Riou L, De Leiris J, Riou B et al (2010) Intramyocardial protein therapy with vascular endothelial growth factor (VEGF-165) induces functional angiogenesis in rat senescent myocardium. J Physiol Pharmacol 61:651-661
19. Yang K, Zhang TP, Tian C, Jia LX, Du J, Li HH (2012) Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling. Am J Hypertens 25:994-1001
20. Zhang Y, Kang YM, Tian C, Zeng Y, Jia LX, Ma X et al (2011) Overexpression of Nrdp1 in the heart exacerbates doxorubicininduced cardiac dysfunction in mice. PLoS One 6:e21104
21. Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ et al (2007) Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest 117:3211-3223 (Pubitemid 350096979)
22. Wang L, Li YL, Zhang CC, Cui W, Wang X, Xia Y et al (2013) Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. Cardiovasc Res 101:383-392
23. Song L, Yang H, Wang HX, Tian C, Liu Y, Zeng XJ et al (2013) Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways. Apoptosis 19:567-580
24. Lu Q, Yao Y, Yao Y, Liu S, Huang Y, Lu S et al (2012) Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model. PLoS One 7:e46998
25. Hamacher-Brady A, Brady NR, Gottlieb RA (2006) The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 20:445-462 (Pubitemid 46150867)
26. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH (2005) Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 18:335-350 (Pubitemid 43123614)
27. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y et al (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444-448 (Pubitemid 46474597)
28. Song H, Yin D, Liu Z (2012) GDF-15 promotes angiogenesis through modulating p53/HIF-1alpha signaling pathway in hypoxic human umbilical vein endothelial cells. Mol Biol Rep 39:4017-4022
29. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S et al (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074-1081 (Pubitemid 37485038)
30. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677-684 (Pubitemid 36749216)
31. Xu CW, Zhang TP, Wang HX, Yang H, Li HH (2013) CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice. Cell Physiol Biochem 31:199-208
32. Li ZD, Bork JP, Krueger B, Patsenker E, Schulze-Krebs A, Hahn EG et al (2005) VEGF induces proliferation, migration, and TGF-beta1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 334:1049-1060 (Pubitemid 41074681)
33. Ushio-Fukai M, Alexander RW (2004) Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264:85-97 (Pubitemid 39366107)
34. Liu W, Schoenkerman A, Lowe WL Jr (2000) Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab 279:E782-E790
35. Valdembri D, Serini G, Vacca A, Ribatti D, Bussolino F (2002) In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J 16:225-227
36. Osugi T, Oshima Y, Fujio Y, Funamoto M, Yamashita A, Negoro S et al (2002) Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J Biol Chem 277:6676-6681 (Pubitemid 34968469)
37. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J et al (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008 (Pubitemid 34270888)